Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEAT trial of extended-release and oral naltrexone for heroin addiction
2013-002584-25Phase 3Terminated
- Sponsor
- King's College London
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of naltrexone in opioid use disorder (OUD) and heroin addiction (3 arms), sponsored by King's College London. Primary endpoint: Primary clinical endpoint. Started Aug 2014; status: terminated.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)heroin addiction
Beyond the preview
Go deeper on 2013-002584-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002584-25.